Author (year) | Population /sample | Country of origin | Study designer | Sequel time |
---|---|---|---|---|
Ribeiro et al., 2016 [15] | 1 male (57 years old) | Brazil | Case report | 5 months after initial symptoms) and 10 days later. |
Oliveira and Silva [9] | 1 woman (35 years old) | Brazil | Case report | After 5 months of the onset of symptoms, in July 2016. |
Silva-Filho et al., 2018 [16] | 20 individuals (both sexes between 18 and 65 years old) | Brazil | Randomized controlled trial | After 6 months of the onset of symptoms. |
Coutinho et al., 2018 [17] | 102 individuals (both sexes over 18 years old) | Brazil | Retrospective, analytical study | From 0 to 90 days after symptoms |
Oliveira, et al., 2019 [18] | 51 individuals (both sexes over 18 years old) | Brazil | Randomized controlled trial | More than 3 months |
Neumann et al., 2019 [19] | 31 subjects (both sexes aged 18–75 years) | Brazil | Randomized controlled trial | More than 3 months |
Siqueira, et al., 2019 [20] | 35 individuals (both sexes over 18 years old) | Brazil | Controlled and randomized clinical trial | More than 3 months |
Neumann et al., 2019 [21] | 31 subjects (both sexes aged 18–75 years) | Brazil | Controlled and randomized clinical trial | More than 3 months |
Oliveira [22] | 51 individuals (both sexes over 18 years old) | Brazil | Randomized controlled trial | More than 3 months |
Silva et al., 2020 [23] | 21 women (40–60 years old) | Brazil | Randomized controlled trial | Does not report |
Tenório et al., 2020 [24] | 2 women (47–58 years old) | Brazil | Case reports | Does not report |
Souza et al., 2021 [25] | 58 women (28 to 70 years old) | Brazil | Randomized clinical trial. | More than 3 months |
Almeida et al. 2021 [26] | 21 individuals (both sexes over 18 years old) | Brazil | Quasi-experimental, uncontrolled and non-randomized study, with pre- and post-test in a single group | After the acute phase of infection, which is considered to be up to 10 days |